Category Venues

WIPO Members Agree New Text On IP And Genetic Resources; Move Talks Forward

World Intellectual Property Organization members negotiating for an instrument to protect against theft of genetic resources last week agreed on a new text with more options on legal terms, effectively moving the talks forward. In this round of talks, the African Group showed signs of moving off its position of revoking patents for violators, while the United States came out strongly against disclosure of origin at the expense of amiable relations with key allies.

IP-Watch Seeking Writers In Brussels, Washington

Intellectual Property Watch is seeking occasional Freelance Writers based in the Washington DC Metro area, San Francisco Bay area, and in Brussels or London. Writers will assist with reporting, writing and publishing stories on international intellectual property and innovation policymaking and law. We are looking for writers who are experienced with delivering multimedia content on a digital news platform and through social media.

Q&A With Erich Spangenberg On Patents And Drug Prices

Prices for drugs have long been a problem for developing countries but now have become out of reach for many in developed countries, sparking policy debates and efforts to address it. One of the top figures in the patent monetization business, industry maverick Erich Spangenberg offers a lively opinion on the underlying problem and how to fix it. To start? Stop granting patent extensions for minor changes.

Interview – Indigenous Concern Over Rising Focus On IP In WIPO TK Talks

Indigenous peoples have been the victims of repeated acts of biopiracy while the international community has failed to act to prevent it, indigenous representatives said in an interview this week. The World Intellectual Property Organization has been discussing ways to address that issue for some 16 years, without success. As negotiators continue to seek consensus on what a potential treaty could achieve, indigenous peoples feel the spotlight has drifted from their issues to technical issues of the intellectual property system and highlighted attention on users of the system.

At WIPO, US Plays Hypotheticals With Swiss Law On Disclosure Of Genetic Resources In Patents

With discussions in full swing at the World Intellectual Property Organization on how to protect genetic resources in intellectual property rights, and in particular whether the disclosure of the source of genetic resources should be mandatory in patent applications, the United States has tabled a document hypothetically applying the mandatory disclosure legislation of Switzerland to a US patent.

Innovation And Access: Fission Or Fusion? Interview With Dr. Kristina M. Lybecker, Associate Professor Of Economics At Colorado College

In the light of the UN High-Level Panel on Access to Medicines, this series of sponsored articles challenges experts to give their views on the policies that best support the development of solutions to societies’ greatest challenges and how enabling policy environments, including IP systems, influence the development and flow of new technologies and services in different sectors, fields of technology, and jurisdictions. The views expressed in the articles are those of the authors. Below is an interview with Dr. Kristina M. Lybecker, Associate Professor of Economics at Colorado College in Colorado Springs (US).

European Commission Eyes Update Of EU Standards-Setting Policy

As standardisation increasingly takes place at the global level, Europe needs a speedier, more streamlined way to set the technical specifications that define requirements for products, production processes, services and test methods, the European Commission said today. As part of its single market strategy, the EC announced plans for a joint initiative on standardisation (JIS), guidance to boost the development of European standards, and an annual reporting system among EU institutions on how the standardisation policy is working and contributing to competitiveness, jobs and growth.

WHO-Led Study: Hepatitis C Treatment Unaffordable Globally, Threatens Health Systems

According to a new study by experts at the World Health Organization, prices of hepatitis C treatments are unaffordable globally and put a major strain on national health systems. Hepatitis C can cause liver cirrhosis and cancer, and with an estimated 80 million people affected in the world, if untreated, the sickness could lead to 700,000 deaths per year worldwide, the study said, suggesting that governments and industry stakeholders should develop and implement fair pricing frameworks.